Literature DB >> 16863896

Health outcomes of patients undergoing cardiac surgery: repeated measures using Short Form-36 and 15 Dimensions of Quality of Life questionnaire.

Doug Elliott1, Ross Lazarus, Stephen R Leeder.   

Abstract

OBJECTIVE: The study assessed health-related quality of life (HRQOL) of patients before and after cardiac surgery.
DESIGN: This was a prospective repeated-measures observational study.
SETTING: The study took place in a 650-bed tertiary referral hospital in Sydney, Australia.
METHODS: HRQOL was measured using the Medical Outcomes Study Short Form 36-item health survey (SF-36) and the 15 Dimensions of Quality of Life questionnaire before surgery, at hospital discharge, and 6 months postdischarge.
RESULTS: Participants were representative of the cardiac surgery population. Scores for several concepts deteriorated at hospital discharge when compared with presurgery. There were significant improvements in health status at 6 months postdischarge when compared with previous measures for the majority of SF-36 and 15 Dimensions of Quality of Life questionnaire concepts, although mental health and social functioning demonstrated significant deterioration. SF-36 scores were substantially lower than population norms, but similar to previous studies of patients undergoing cardiac surgery except for mental health.
CONCLUSION: Deterioration in health status at hospital discharge when compared with presurgery status reinforces the need for further patient care and support after discharge. All dimensions improved after 6 months, except mental health. This information can guide patient expectations regarding rehabilitation posthospitalization, and cardiac surgical services should implement and evaluate formal "outreach programs" for these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16863896     DOI: 10.1016/j.hrtlng.2005.10.004

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  7 in total

1.  Health-related quality of life evaluated by the eight-item short form after cardiovascular surgery.

Authors:  Takayoshi Kato; Shinji Tomita; Nobuhiro Handa; Yo-ichiro Ueno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-12-18

2.  Health-related quality of life of patients after mechanical valve replacement surgery for rheumatic heart disease in a developing country.

Authors:  Linda J Thomson Mangnall; David W Sibbritt; Margaret Fry; Melanie Windus; Robyn D Gallagher
Journal:  Heart Asia       Date:  2014-12-09

3.  Improving family caregiver and patient outcomes in lung cancer surgery: Study protocol for a randomized trial of the multimedia self-management (MSM) intervention.

Authors:  Virginia Sun; Dan J Raz; Loretta Erhunmwunsee; Nora Ruel; Jacqueline Carranza; Rosemary Prieto; Betty Ferrell; Robert S Krouse; Ruth McCorkle; Jae Y Kim
Journal:  Contemp Clin Trials       Date:  2019-07-03       Impact factor: 2.226

4.  Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome.

Authors:  Samuel M Brown; Emily Wilson; Angela P Presson; Chong Zhang; Victor D Dinglas; Tom Greene; Ramona O Hopkins; Dale M Needham
Journal:  Thorax       Date:  2016-07-20       Impact factor: 9.139

5.  Influence of a symptom management telehealth intervention on older adults' early recovery outcomes after coronary artery bypass surgery.

Authors:  Susan Barnason; Lani Zimmerman; Janet Nieveen; Paula Schulz; Connie Miller; Melody Hertzog; Chunhao Tu
Journal:  Heart Lung       Date:  2009 Sep-Oct       Impact factor: 2.210

6.  The effects of cardiac tertiary prevention program after coronary artery bypass graft surgery on health and quality of life.

Authors:  Azam Mosayebi; Shaghayegh Haghjooy Javanmard; Mohsen Mirmohamadsadeghi; Reza Rajabi; Samaneh Mostafavi; Marjan Mansourian
Journal:  Int J Prev Med       Date:  2011-10

7.  Quality of life one year after coronary artery bypass graft surgery.

Authors:  H R Taghipour; M H Naseri; R Safiarian; Y Dadjoo; B Pishgoo; H A Mohebbi; L Daftari Besheli; M Malekzadeh; A Kabir
Journal:  Iran Red Crescent Med J       Date:  2011-03-01       Impact factor: 0.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.